Search
AstraZeneca Launches Global Strategic R&D Center in Beijing
2025-10-25 /
Read about 0 minute
Author：小编
On October 25, 2025, AstraZeneca officially launched its sixth global and second strategic R&D center in China in Beijing. As the core project of a $2.5 billion investment plan in China, this center houses an Artificial Intelligence and Data Science Center, aiming to accelerate the translation of early-stage drug research achievements into clinical development.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
